Delivery Order SPE2DR25D1202-SPE2DR26F74JG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,793.70 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside contract was awarded on January 30, 2026, with an ultimate completion date of February 2, 2026. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,398.07 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This competitive, firm fixed-price delivery order has an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order execution under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $28,711.87 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units) on January 16, 2026, with completion expected by January 20, 2026. This firm fixed-price delivery order was issued on a non-set-aside basis under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $76,221.78 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalation powder, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The award was made on January 30, 2026, with an ultimate completion date of February 2, 2026, and utilized firm fixed-price pricing with no small business set-aside. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,046.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The award, issued December 1, 2025, with completion targeted for December 2, 2025, was made on a firm fixed-price basis without set-aside restrictions, indicating competitive award through open procurement. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,824.34 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count packaging) on January 28, 2026, with ultimate completion by January 29, 2026. This competitive award, utilizing firm fixed-price pricing with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to...
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,668.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a completion date of November 17, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations for federal...
- The Defense Logistics Agency awarded a $21,499.39 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for November 21, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order is executed under AmerisourceBergen's larger...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74JGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,319.82 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on January 30, 2026, with an ultimate completion date of February 2, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999,999,999.00 single-award vehicle running through December 31, 2031, which serves as the primary procurement mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through this IDC framework. The parent company, Cencora, Inc., competes on a full and open basis for federal contracts and maintains a significant portfolio of pharmaceutical deliveries to the Department of Defense and other federal healthcare systems. The Trelegy Ellipta delivery exemplifies the company's role in supplying brand-name medications across multiple therapeutic domains to support military treatment facilities and defense health programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 1/29/26 |